We report on p27 and cyclin E immunoreactivity (IR) in 86 patients with myelodysplastic syndromes (MDS). No association was found between cyclin E IR and survival in the whole series. Cyclin E IR was more prevalent in patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) with poor survival, although this trend was not statistically significant.
The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes / G. Pruneri, N. Fracchiolla, A. Cortelezzi, M. Ponzoni, P. Maisonneuve, G. Lambertenghi Deliliers. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 88:1(2003 Jan), pp. 109-110.
The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes
G. Pruneri;A. Cortelezzi;G. Lambertenghi Deliliers
2003
Abstract
We report on p27 and cyclin E immunoreactivity (IR) in 86 patients with myelodysplastic syndromes (MDS). No association was found between cyclin E IR and survival in the whole series. Cyclin E IR was more prevalent in patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) with poor survival, although this trend was not statistically significant.
| File | Dimensione | Formato | |
|---|---|---|---|
|
109.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
84.17 kB
Formato
Adobe PDF
|
84.17 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
